Clinical Trial Update: Open Label Trial for Post-Menopausal Women With Newly Diagnosed Operable Breast Cancer [Phase 2]

View source ↗

Summary

Open-label Phase 2 clinical trial in postmenopausal women with newly diagnosed operable breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED